NewAmsterdam Pharma Co N.V. ($NAMS)
Filing Information
| Accession Number | 0001193125-26-412431 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 2, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
150,738
Total Value
$1,257,657.38
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Ordinary Shares | โ | Sep 30, 2026 | Exercise/Conversion | 50,246 | โ | โ | 119,548 | Indirect | See footnotes | View Details | |
Director | Ordinary Shares | โ | Sep 30, 2026 | Sale | 50,246 | $25.03 | $1,257,657.38 | 69,302 | Indirect | See footnotes | View Details | |
Director | Option (right to buy) | Derivative | Sep 30, 2026 | Exercise/Conversion | 50,246 | $0.00 | $0.00 | 344,983 | Indirect | See footnote | View Details |